Caribou Biosciences Ownership | Who Owns Caribou Biosciences?
Caribou Biosciences Ownership Summary
Caribou Biosciences is owned by 15.92% institutional investors, 8.91% insiders, and 75.17% retail investors. Blackrock is the largest institutional shareholder, holding 7.78% of CRBU shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.75% of its assets in Caribou Biosciences shares.
CRBU Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Caribou Biosciences | 15.92% | 8.91% | 75.17% |
| Sector | Healthcare Stocks | 35.52% | 11.86% | 52.62% |
| Industry | Biotech Stocks | 35.67% | 11.81% | 52.52% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 6.95M | 7.78% | $11.39M |
| Pfizer | 4.69M | 5.02% | $8.35M |
| Bank of america corp /de/ | 4.16M | 4.66% | $6.83M |
| Vanguard group | 4.30M | 4.61% | $6.84M |
| Renaissance | 2.59M | 2.77% | $4.92M |
| Kynam capital management, lp | 2.50M | 2.68% | $4.76M |
| Blackrock funding, inc. /de | 2.14M | 2.29% | $4.07M |
| Two sigma investments, lp | 1.76M | 1.88% | $3.34M |
| Two sigma advisers, lp | 1.23M | 1.32% | $2.86M |
| Abrdn | 1.21M | 1.30% | $2.30M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Pfizer | 4.69M | 3.50% | $8.35M |
| 72 investment | 474.07K | 1.82% | $900.73K |
| Green alpha advisors | 373.65K | 0.70% | $709.93K |
| Kynam capital management, lp | 2.50M | 0.29% | $4.76M |
| Nano cap new millennium growth fund l p | 117.50K | 0.21% | $223.25K |
| Pfm health sciences, lp | 957.79K | 0.17% | $1.82M |
| Bruce | 250.00K | 0.14% | $475.00K |
| Milestone asset management | 162.08K | 0.06% | $307.94K |
| Gsa capital partners llp | 480.72K | 0.06% | $913.00K |
| Diametric capital, lp | 32.79K | 0.02% | $62.31K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bank of america corp /de/ | 4.16M | 0.00% | 3.05M |
| Renaissance | 2.59M | 0.01% | 950.64K |
| Mackenzie financial | 942.79K | 0.00% | 942.79K |
| Acadian asset management | 925.04K | 0.00% | 865.32K |
| Two sigma investments, lp | 1.76M | 0.00% | 739.86K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avidity partners management lp | - | - | -5.79M |
| Alkeon capital management | - | - | -2.74M |
| Paradigm biocapital advisors lp | - | - | -2.17M |
| Fil | - | - | -860.67K |
| Rokos capital management llp | - | - | -840.63K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Mackenzie financial | 942.79K | 0.00% | 942.79K | $1.79M |
| Vanguard fiduciary trust | 520.12K | 0.00% | 520.12K | $988.22K |
| Hrt financial lp | 78.95K | 0.00% | 78.95K | $150.00K |
| Brevan howard capital management lp | 65.06K | 0.00% | 65.06K | $123.62K |
| Virtu financial | 36.61K | 0.00% | 36.61K | $70.00K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Nbc securities | -2.00 |
| Northwestern mutual wealth management | -4.00 |
| Nelson, van denburg & campbell wealth management group | -17.00 |
| Eversource wealth advisors | -24.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 63 | -50.39% | 14,869,314 | -59.96% | 15 | 1.00% | 24 | -51.02% | 15 | -60.53% |
| Dec 31, 2025 | 80 | -33.88% | 24,665,069 | -33.73% | 26 | 1.65% | 31 | -11.43% | 21 | -56.25% |
| Sep 30, 2025 | 115 | -13.53% | 36,849,134 | -9.66% | 39 | 2.06% | 33 | -46.77% | 46 | 9.52% |
| Jun 30, 2025 | 132 | -0.75% | 40,507,235 | -19.40% | 43 | 1.48% | 61 | 12.96% | 43 | - |
| Mar 31, 2025 | 133 | -1.48% | 50,255,248 | -13.75% | 54 | 1.31% | 54 | -28.00% | 44 | 62.96% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.73M | 2.75% | - |
| ACATIS Datini Valueflex Fonds A | 2.00M | 2.03% | - |
| Selectra J. Lamarck Biotech A | 1.46M | 1.47% | -193.44K |
| abrdn Life Sciences Investors | 1.08M | 1.09% | -136.20K |
| Vanguard Institutional Extnd Mkt Idx Tr | 959.91K | 0.97% | 34.89K |
| Fidelity Small Cap Index | 843.92K | 0.91% | - |
| JPMorgan US Small Company L | 786.21K | 0.87% | -22.84K |
| iShares Russell 2000 Value ETF | 762.12K | 0.82% | - |
| Candriam Global Equities Oncology | 625.00K | 0.69% | -520.00K |
| iShares Biotechnology ETF | 623.32K | 0.63% | 3.95K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 25, 2026 | Kelly Timothy P | Chief Technology Officer | Sell | $12.02K |
| Feb 24, 2026 | Kelly Timothy P | Chief Technology Officer | Sell | $6.17K |
| Feb 24, 2026 | MCCLUNG BARBARA G | Chief Legal Officer | Sell | $13.60K |
| Feb 24, 2026 | Khan Ruhi Ahmad | Chief Business Officer | Sell | $13.60K |
| Feb 24, 2026 | Albertson Tina M. | Chief Medical Officer | Sell | $2.09K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 5 |
| 2025 Q1 | 2 | 3 |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q1 | - | - |
CRBU Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools